RE:RE:RE:RE:News from Taurx Quite happy! Will give investor relations a call soon.
Not to sound like a broken record but TauRx warrants were exercised at the US$45 per share. At the warrant exercise price of $45 per share, TauRx had a market cap of $1.4 billion.
As of March 31st 2023, Dundee owns 3.2% of TauRx Pharmaceuticals Ltd currently valued at $66,250,000. Dundee values TauRx above 2 Billion dollars. TauRx is a non core investment.
"When Biogen and Eisai announced the results of their latest Phase 3 trials on lecanemab, their combined stock prices after they announced the results went up by over $15 billion over the next several days. We believe that TauRx's results were better than those. At the warrant exercise price of $45 per share, TauRx has a market cap of $1.4 billion. If TauRx went up by the same amount as those two stocks, that would imply a share price of over US$450 per share. And we own a little over 1 million shares and that's why I'm spending so much time. This has the potential of being a very significant holding for us." Mr Goodman Q3 2022 Earnings call